[Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
Bani-Sadr
Firouzé
F
Service des Maladies Infectieuses et Tropicales, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10. firouze.bani-sadr@sls.ap-hop-paris.fr
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D018579:Patient Selection; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D000998:Antiviral Agents